In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
In recent findings from the ADvocate1 and ADvocate2 studies, lebrikizumab has shown promising results in treating moderate-to-severe atopic dermatitis.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Researchers aimed to evaluate the effects of texture and color enhancement imaging on improving the endoscopic visibility of esophageal squamous cell carcinoma under iodine staining.
Ritlecitinib, a JAK3/TEC family kinase inhibitor, has shown promising results in the treatment of non-segmental vitiligo (NSV), according to a recent Phase 2b trial.
Ritlecitinib, a JAK3/TEC family kinase inhibitor, has shown promising results in the treatment of non-segmental vitiligo (NSV), according to a recent Phase 2b trial.
The Dermatology Nurses’ Association hosts its 43rd yearly meeting in Orlando, FL, March 5–8, 2025, offering in-person educational and networking opportunities to promote patient care excellence.
The Dermatology Nurses’ Association hosts its 43rd yearly meeting in Orlando, FL, March 5–8, 2025, offering in-person educational and networking opportunities to promote patient care excellence.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...
How should clinicians redefine severe alopecia areata? When is it appropriate to treat ≤20% scalp involvement with oral JAK inhibitors? This expert-level quiz explores remission durability, treatment withdrawal, and practical strategies for...